BUILDING BETTER UNDERSTANDING AGILENT BRAVO PLATFORM BOLSTERS BASIC AND TRANSLATIONAL RESEARCH Dave Weaver does the kind of research you might see at a pharmaceutical company or a biotech firm, but he does it at a highly regarded American university. “We screen large libraries of small molecules against molecular targets, but instead of using those compounds as part of a drug-discovery mission, most of our work focuses on the discovery of mo

Join for free to read